Contagion, August 2023 (Vol. 08, No. 4)

Here is a review of this specific case.

Clinicians offer insights on the individual respiratory viruses as well as addressing management of coinfections.

This is a challenging pathogen, requiring pharmacokinetic and pharmacodynamic considerations; the recent FDA approval of sulbactam-durlobactam offers new hope.

Unique challenges can affect the success of the shift from pediatric to adult care settings.

Viruses and other concerns within medicine are being overlooked; health care preparedness must address these potential crises.

Social media platforms, public health agencies, and communities must join forces to stop the rapid spread of false information.

Although close clinician monitoring is warranted to avoid complications for this this type of treatment, it can be beneficial to patients and help reduce care costs.

With potential delays in treatment, bloodstream infections can be concerning for clinicians. Here is a review of the literature that offer guidance for treatment.

With recent reports of this vector-borne illness in the continental United States, there is concern this might become endemic in the country again.

Patients with a penicillin allergy can be safely delabeled using minimal resources, opening up treatment options.